Clin2
NCT07758660Possibly a fitEnrolling by invitation

Brain scan study for Alzheimer's research

Alzheimer DiseaseMild Cognitive Impairment (MCI)Dementia

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study uses brain scans (PET) to look at changes in the brain that may be related to memory problems or Alzheimer's disease. It aims to improve understanding of the disease and may help develop better treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
50 years and older
Study type
Interventional

Who can take part

  • You must already be enrolled in the Alzheimer's Disease Resource Center (ADRC).
  • You should be able to attend all study visits and complete tests in English or Spanish.
  • You cannot be pregnant or breastfeeding.
  • You should not have conditions like claustrophobia or severe obesity that would make a brain scan difficult.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012993Recruiting· Phase 2
Very low dose PET brain scan study

This study tests whether using a very low dose of radiation for a brain PET scan can still give clear images. If you are eligible, you will get a type of radioactive tracer that helps show amyloid plaques in the brain, often used in Alzheimer's research.

Englewood, New Jersey
NCT07764679Recruiting· Phase 3
Brain scan to detect Alzheimer's plaques

This study tests a new PET brain scan that uses a special dye to show amyloid plaques, which are linked to Alzheimer's disease. It may help doctors see if your memory problems are caused by Alzheimer's or something else.

Beijing, Beijing Municipality
NCT05457998Enrolling by invitation
Study of Alzheimer’s brain markers using memory testing

This trial looks for signs of Alzheimer’s disease in the brain by using memory and thinking tests, and related study procedures. It may help researchers find better ways to identify Alzheimer’s-related changes earlier.

Providence, Rhode Island
NCT04104659Enrolling by invitation
Tau PET scan study to map brain changes in Alzheimer’s

This study tests a PET scan “tracer” medicine called [18F]MK-6240 to see how tau protein changes show up in the brain. It may help researchers measure disease-related brain changes in people with normal thinking or mild dementia.

St Louis, Missouri
NCT05374278Recruiting· Phase 1/Phase 2
PET scan test for a dementia brain tracer

This early-phase study tests a new PET scan tracer that targets a brain chemical transport system involved in dementia. It aims to see if the tracer can safely and clearly show brain changes, which could help future dementia diagnosis or tracking.

San Francisco, California
NCT06254469Recruiting· Phase 3
PET scan study for memory decline with head injury or Alzheimer's risk

This trial uses a special PET scan tracer to see if it can predict who will get worse over time. It is for people with mild memory or thinking problems that may be linked to past head injuries or early Alzheimer's disease.

Evanston, Illinois

Hear when a new Dementia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.